3502 Systematic review of facial deformation following paediatric head-and-neck radiotherapy: A call for standardised outcomes and dose-response evidence.
A. Davey(Cancer Research UK Manchester Institute), M. Aznar, Simona Gaito(University of Manchester), Love Goyal(Cancer Research UK), M. Hol(Princess Máxima Center), Olga Slater(Great Ormond Street Hospital), Bernadette Brennan(Royal Manchester Children's Hospital), Callum Gillies, Shermaine Pan(Proton (United Kingdom)), Lucy Davies, Frances Charlwood(The Christie NHS Foundation Trust), Koen B. Krommenhoek(Princess Máxima Center), Nanouschka H. Maagdenberg(Utrecht University), Emma Foster-Thomas(Manchester University NHS Foundation Trust)
Cited by 0
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419